Recruiting Osteogenesis Imperfecta Studies in New York
About Osteogenesis Imperfecta Clinical Trials in New York
Osteogenesis imperfecta is a group of genetic disorders mainly affecting the bones, causing them to break easily, often from little or no apparent cause. It is caused by defects in collagen production. Treatment includes bisphosphonates, physical therapy, and surgical rodding.
There are currently 100 osteogenesis imperfecta clinical trials recruiting participants in New York, NY. These studies are seeking a combined 26,186 participants. Research is being sponsored by Tirgan, Michael H., M.D., Alnylam Pharmaceuticals, Baylor College of Medicine and 57 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Osteogenesis Imperfecta Clinical Trials in New York — FAQ
Are there osteogenesis imperfecta clinical trials in New York?
Yes, there are 100 osteogenesis imperfecta clinical trials currently recruiting in New York, NY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What osteogenesis imperfecta treatments are being tested?
The 100 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for osteogenesis imperfecta.
Data updated September 1, 2026 from ClinicalTrials.gov